NAYA BIOSCIENCES INC (NAYA) Fundamental Analysis & Valuation

NASDAQ:NAYA • US44984F4019

Current stock price

2.2 USD
+0.17 (+8.37%)
At close:
2.34 USD
+0.14 (+6.36%)
After Hours:

This NAYA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. NAYA Profitability Analysis

1.1 Basic Checks

  • In the past year NAYA has reported negative net income.
  • NAYA had a negative operating cash flow in the past year.
  • NAYA had negative earnings in each of the past 5 years.
  • NAYA had negative operating cash flow in 4 of the past 5 years.
NAYA Yearly Net Income VS EBIT VS OCF VS FCFNAYA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 -2M -4M -6M -8M -10M

1.2 Ratios

  • NAYA's Return On Assets of -43.87% is on the low side compared to the rest of the industry. NAYA is outperformed by 64.21% of its industry peers.
Industry RankSector Rank
ROA -43.87%
ROE N/A
ROIC N/A
ROA(3y)-122.53%
ROA(5y)-112.88%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NAYA Yearly ROA, ROE, ROICNAYA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 500 -500 1K

1.3 Margins

  • With a Gross Margin value of 42.40%, NAYA is not doing good in the industry: 66.32% of the companies in the same industry are doing better.
  • NAYA's Gross Margin has declined in the last couple of years.
  • NAYA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 42.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.71%
GM growth 5Y-15.12%
NAYA Yearly Profit, Operating, Gross MarginsNAYA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 -1K -2K -3K -4K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. NAYA Health Analysis

2.1 Basic Checks

  • NAYA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for NAYA has been increased compared to 1 year ago.
  • The debt/assets ratio for NAYA has been reduced compared to a year ago.
NAYA Yearly Shares OutstandingNAYA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M 2M
NAYA Yearly Total Debt VS Total AssetsNAYA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

2.2 Solvency

  • Based on the Altman-Z score of -6.38, we must say that NAYA is in the distress zone and has some risk of bankruptcy.
  • NAYA's Altman-Z score of -6.38 is on the low side compared to the rest of the industry. NAYA is outperformed by 73.16% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -6.38
ROIC/WACCN/A
WACC6.25%
NAYA Yearly LT Debt VS Equity VS FCFNAYA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M -4M 6M -6M

2.3 Liquidity

  • A Current Ratio of 0.23 indicates that NAYA may have some problems paying its short term obligations.
  • With a Current ratio value of 0.23, NAYA is not doing good in the industry: 95.79% of the companies in the same industry are doing better.
  • NAYA has a Quick Ratio of 0.23. This is a bad value and indicates that NAYA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.20, NAYA is doing worse than 96.32% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.23
Quick Ratio 0.2
NAYA Yearly Current Assets VS Current LiabilitesNAYA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. NAYA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 76.18% over the past year.
  • The Revenue has grown by 224.37% in the past year. This is a very strong growth!
  • The Revenue has been growing by 43.87% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)76.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.06%
Revenue 1Y (TTM)224.37%
Revenue growth 3Y42.68%
Revenue growth 5Y43.87%
Sales Q2Q%47.75%

3.2 Future

  • The Earnings Per Share is expected to decrease by -100.83% on average over the next years. This is quite bad
  • Based on estimates for the next years, NAYA will show a very strong growth in Revenue. The Revenue will grow by 101.26% on average per year.
EPS Next Y-3770%
EPS Next 2Y-144.95%
EPS Next 3Y-100.83%
EPS Next 5YN/A
Revenue Next Year125.23%
Revenue Next 2Y57.41%
Revenue Next 3Y39.68%
Revenue Next 5Y101.26%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NAYA Yearly Revenue VS EstimatesNAYA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M
NAYA Yearly EPS VS EstimatesNAYA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 -50 -100 -150 -200

More info and screens

Find the best growth stocksShow best growing peers

0

4. NAYA Valuation Analysis

4.1 Price/Earnings Ratio

  • NAYA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NAYA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NAYA Price Earnings VS Forward Price EarningsNAYA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NAYA Per share dataNAYA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 -10

4.3 Compensation for Growth

  • NAYA's earnings are expected to decrease with -100.83% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-144.95%
EPS Next 3Y-100.83%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. NAYA Dividend Analysis

5.1 Amount

  • No dividends for NAYA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

NAYA Fundamentals: All Metrics, Ratios and Statistics

NAYA BIOSCIENCES INC

NASDAQ:NAYA (4/25/2025, 8:25:39 PM)

After market: 2.34 +0.14 (+6.36%)

2.2

+0.17 (+8.37%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)04-30
Earnings (Next)05-13
Inst Owners2.88%
Inst Owner Change-100%
Ins Owners1.05%
Ins Owner ChangeN/A
Market Cap1.47M
Revenue(TTM)6.23M
Net Income(TTM)-7.47M
Analysts82.86
Price Target6.12 (178.18%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)200%
PT rev (3m)200%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1100%
EPS NY rev (1m)0%
EPS NY rev (3m)-1100%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-24.84%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.24
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.96
EYN/A
EPS(NY)-2.45
Fwd EYN/A
FCF(TTM)-4.85
FCFYN/A
OCF(TTM)-4.59
OCFYN/A
SpS9.3
BVpS-0.03
TBVpS-14
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -43.87%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 42.4%
FCFM N/A
ROA(3y)-122.53%
ROA(5y)-112.88%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.71%
GM growth 5Y-15.12%
F-Score3
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 21.66%
Cap/Sales 2.88%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.23
Quick Ratio 0.2
Altman-Z -6.38
F-Score3
WACC6.25%
ROIC/WACCN/A
Cap/Depr(3y)577.95%
Cap/Depr(5y)746.77%
Cap/Sales(3y)8.92%
Cap/Sales(5y)8.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)76.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.06%
EPS Next Y-3770%
EPS Next 2Y-144.95%
EPS Next 3Y-100.83%
EPS Next 5YN/A
Revenue 1Y (TTM)224.37%
Revenue growth 3Y42.68%
Revenue growth 5Y43.87%
Sales Q2Q%47.75%
Revenue Next Year125.23%
Revenue Next 2Y57.41%
Revenue Next 3Y39.68%
Revenue Next 5Y101.26%
EBIT growth 1Y29.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y52.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y56.79%
OCF growth 3YN/A
OCF growth 5YN/A

NAYA BIOSCIENCES INC / NAYA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of NAYA BIOSCIENCES INC (NAYA) stock?

ChartMill assigns a fundamental rating of 1 / 10 to NAYA.


What is the valuation status for NAYA stock?

ChartMill assigns a valuation rating of 0 / 10 to NAYA BIOSCIENCES INC (NAYA). This can be considered as Overvalued.


How profitable is NAYA BIOSCIENCES INC (NAYA) stock?

NAYA BIOSCIENCES INC (NAYA) has a profitability rating of 0 / 10.


Can you provide the expected EPS growth for NAYA stock?

The Earnings per Share (EPS) of NAYA BIOSCIENCES INC (NAYA) is expected to decline by -3770% in the next year.